Abderraouf Hilali

Mr. Abderraouf Hilali


Research Focus & Metrics

Academic Career Length

4Years (2023-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications

11 October 2023 in F1000Research
Verified
Journal Article
Open access
PDF file
MAMaryem ARRAJI
Maryem ARRAJI
ANAl Wachami Nadia
Al Wachami Nadia
YIYounes Iderdar
Younes Iderdar
AHAbderraouf Hilali
Abderraouf Hilali
MYMourajid Yassmine
Mourajid Yassmine
MCMohamed Chahboune
Mohamed Chahboune
Background: The aim of this study was to assess medication adherence among Moroccan patients with type 2 diabetes. Methods: To achieve this objective, a quantitative cross-sectional study was conducted among patients with type 2 diabetes in Morocco. The General Medication Adherence Scale (GMAS) was used to measure medication adherence in this target population. The study received ethical approval from the Moroccan Association for Research and Ethics. Results: A total of 284 patients were included in the study. Among them, 90.30% of type 2 diabetes patients demonstrated high adherence to their medication treatment, while 5.30% were considered to have moderate adherence and only 4.40% showed partial adherence. However, when the cumulative evaluation of medication adherence towards antidiabetic drugs was conducted, the results confirmed an adherence rate of approximately 95.78%. Conclusions: The study's findings revealed a high level of medication adherence among type 2 diabetes patients. To sustain these encouraging results, it will be crucial to maintain and value the efforts made by healthcare professionals involved in the care of these patients.

28 February 2025 in Osong Public Health and Research Perspectives
Verified
Journal Article
Open access
AHAbderraouf Hilali
Abderraouf Hilali
MCMohamed Chahboune
Mohamed Chahboune
GMGuennouni Morad
Guennouni Morad
AHAbderraouf Hilali
Abderraouf Hilali
Objectives: The objectives of this review and meta-analysis were twofold: first, to determine the prevalence of substance use among school-going children in Arab and African countries; and second, to highlight the considerable influence of variables such as the nation’s region and the timeframe of the study on the prevalence of substance use.Methods: Research was sourced from Science Direct, Scopus, Web of Science, Google Scholar, and PubMed. Thirty-seven articles were incorporated in accordance with the PRISMA guidelines. This review included studies published from 2013 to 2023. The statistical meta-analysis was performed using Comprehensive Meta-Analysis ver. 3 software. Across 37 studies, the total number of study participants was 73,508.Results: The meta-analysis revealed that tobacco was the most commonly used substance, with a prevalence of 16% (95% confidence interval [CI], 12.7%–20.02%). This was closely followed by alcohol, which had a prevalence of 15% (95% CI, 10.5%–22.8%), stimulants at 11.4% (95% CI, 7.4%–17%), khat at 10% (95% CI, 5.7%–15%), and cannabis at 8% (95% CI, 3.3%–18.4%). Notably, alcohol was the only substance that showed an increasing trend in prevalence from before to after 2019, rising from 13.3% (95% CI, 6.2%–26.1%) to 17% (95% CI, 10.2%–27%) (p<0.001). Additionally, the prevalence of substance use varied significantly between Arab and African countries (p<0.001).Conclusion: Although the prevalence of substance use among school-going populations has significantly decreased over time, with the exception of alcohol, it is imperative that both African and Arab countries implement comprehensive measures and stringent laws to address the production and marketing of substances.

19 January 2026 in Substance Abuse Treatment, Prevention, and Policy
Verified
Journal Article
Open access
PDF file
AHAbderraouf Hilali
Abderraouf Hilali
MCMohamed Chahboune
Mohamed Chahboune
MGMorad Guennouni
Morad Guennouni
AHAbderraouf Hilali
Abderraouf Hilali
Adolescent substance use poses significant public health challenges, yet data in Morocco are scarce. This study investigates the prevalence and associated

12 May 2026
Verified
Book Chapter
Closed access
AHAbderraouf Hilali
Abderraouf Hilali
MCMohamed Chahboune
Mohamed Chahboune
GMGuennouni Morad
Guennouni Morad
AHAbderraouf Hilali
Abderraouf Hilali